TGA
- Status: likely_approved
🇦🇺 Chrft5 in Australia
Chrft5 (BASILIXIMAB) regulatory status in Australia.
Marketing authorisation
Chrft5 in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Immunology approved in Australia
Frequently asked questions
Is Chrft5 approved in Australia?
Yes. TGA has authorised it.
Who is the marketing authorisation holder for Chrft5 in Australia?
Novartis is the originator. The local marketing authorisation holder may differ — check the official source linked above.